SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-19-002987
Filing Date
2019-03-07
Accepted
2019-03-07 16:06:40
Documents
63
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm 10-K 1048730
2 ex31-1.htm EX-31.1 12999
3 ex31-2.htm EX-31.2 12982
4 ex32.htm EX-32 7033
  Complete submission text file 0001493152-19-002987.txt   3969764

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE pvct-20181231.xml EX-101.INS 534308
6 XBRL SCHEMA FILE pvct-20181231.xsd EX-101.SCH 45044
7 XBRL CALCULATION FILE pvct-20181231_cal.xml EX-101.CAL 53974
8 XBRL DEFINITION FILE pvct-20181231_def.xml EX-101.DEF 166940
9 XBRL LABEL FILE pvct-20181231_lab.xml EX-101.LAB 333073
10 XBRL PRESENTATION FILE pvct-20181231_pre.xml EX-101.PRE 258608
Mailing Address 10025 INVESTMENT DRIVE SUITE 250 KNOXVILLE TN 37932
Business Address 10025 INVESTMENT DRIVE SUITE 250 KNOXVILLE TN 37932 865-769-4011
PROVECTUS BIOPHARMACEUTICALS, INC. (Filer) CIK: 0000315545 (see all company filings)

IRS No.: 900031917 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36457 | Film No.: 19665901
SIC: 2834 Pharmaceutical Preparations